PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells Journal Article


Authors: Agrawal Singh, S.; Lerdrup, M.; Gomes, A. L. R.; van de Werken, H. J.; Vilstrup Johansen, J.; Andersson, R.; Sandelin, A.; Helin, K.; Hansen, K.
Article Title: PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells
Abstract: The PLZF transcription factor is essential for osteogenic differentiation of hMSCs; however, its regulation and molecular function during this process is not fully understood. Here, we revealed that the ZBTB16 locus encoding PLZF, is repressed by Polycomb (PcG) and H3K27me3 in naive hMSCs. At the pre-osteoblast stage of differentiation, the locus lost PcG binding and H3K27me3, gained JMJD3 recruitment, and H3K27ac resulting in high expression of PLZF. Subsequently, PLZF was recruited to osteogenic enhancers, influencing H3K27 acetylation and expression of nearby genes important for osteogenic function. Furthermore, we identified a latent enhancer within the ZBTB16/PLZF locus itself that became active, gained PLZF, p300 and Mediator binding and looped to the promoter of the nicotinamide N-methyltransferase (NNMT) gene. The increased expression of NNMT correlated with a decline in SAM levels, which is dependent on PLZF and is required for osteogenic differentiation. © 2019, Agrawal Singh et al.
Keywords: gene expression; osteogenesis; chromosomes; plzf; human; human mesenchymal stem cells; developmental enhancer; histone h3 lysine 27 tri-methylation; polycomb proteins; zbtb16
Journal Title: eLife
Volume: 8
ISSN: 2050-084X
Publisher: eLife Sciences Publications Ltd.  
Date Published: 2019-01-23
Start Page: e40364
Language: English
DOI: 10.7554/eLife.40364
PUBMED: 30672466
PROVIDER: scopus
PMCID: PMC6344081
DOI/URL:
Notes: Article -- Export Date: 1 March 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kristian Helin
    35 Helin